More SEC Filings
View Older Stories View Newer Stories-
Form 4 Altair Engineering Inc. For: Mar 22 Filed by: Christ Revocable Trust
-
Form 144 Porch Group, Inc. Filed by: Tabak Shawn
-
Form 424B2 JPMORGAN CHASE & CO
-
Form 424B2 MORGAN STANLEY
-
Form D OV Cameo SPV 2024, LLC
-
Form 8-A12B Harden Technologies Inc.
-
Form FWP HSBC USA INC /MD/ Filed by: HSBC USA INC /MD/
-
Form 24F-2NT Meeder Funds For: Dec 31
-
Form 424B2 BARCLAYS BANK PLC
-
Form 424B2 TORONTO DOMINION BANK
-
Form 424B2 BARCLAYS BANK PLC
-
Form 24F-2NT Meeder Funds For: Dec 31
-
Form 424B3 C3is Inc.
-
Form 424B2 JPMORGAN CHASE & CO
-
Form D/A Quarba Partners, LP
-
Form 424B2 MORGAN STANLEY
-
Form 424B2 BARCLAYS BANK PLC
-
Form 424B2 BARCLAYS BANK PLC
-
Form FWP GS Finance Corp. Filed by: GS Finance Corp.
-
Form 424B2 JPMORGAN CHASE & CO
-
Form 10-K GS Mortgage Securities For: Dec 31
-
Form D EquityZen Growth Technol
-
Form 4 Macy's, Inc. For: Mar 24 Filed by: Griscom Paul
-
Form FWP GOLDMAN SACHS GROUP INC Filed by: GOLDMAN SACHS GROUP INC
-
Form 424B3 C3is Inc.
-
Form 424B2 CITIGROUP INC
-
Form D PEP II Alligood Industri
-
Form 424B2 BARCLAYS BANK PLC
-
Form 4 Macy's, Inc. For: Mar 24 Filed by: Kirgan Danielle L.
-
Form 8-K MRC GLOBAL INC. For: Mar 26
-
Form 4 BIG 5 SPORTING GOODS For: Mar 22 Filed by: DUNBAR JENNIFER HOLDEN
-
Form 424B2 JPMORGAN CHASE & CO
-
Form 424B3 BANK OF NOVA SCOTIA
-
Form D Cell MedX Corp.
-
Form 4 BIG 5 SPORTING GOODS For: Mar 22 Filed by: Jessick David
-
Form 24F-2NT GUGGENHEIM DEFINED PORTF For: Jan 31
-
Form 424B2 JPMORGAN CHASE & CO
-
Form 4 Macy's, Inc. For: Mar 24 Filed by: Mitchell Adrian V
-
Form 424B2 MORGAN STANLEY
-
Form 424B2 JPMORGAN CHASE & CO
-
Form 424B2 CITIGROUP INC
-
Form 424B2 JPMORGAN CHASE & CO
-
Form TA-2 ULTIMUS FUND SOLUTIONS For: Dec 31
-
Form 6-K C3is Inc. For: Mar 26
-
Form 24F-2NT BAILLIE GIFFORD FUNDS For: Dec 31
-
Form 424B2 JPMORGAN CHASE & CO
-
Form 4 Macy's, Inc. For: Mar 24 Filed by: Spring Antony
-
Form D/A Anantam International
-
Form 24F-2NT KMA VARIABLE ACCOUNT For: Dec 31
-
Form 8-K ACURA PHARMACEUTICALS, For: Mar 25

